Home › Immuunsysteem en aandoeningen › Texas › Houston
Immuunsysteem en aandoeningen klinische studies in Houston, TX
9 studies voor Immuunsysteem en aandoeningen zoeken deelnemers op locaties in en rond Houston (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
RekruterenFase 1
- The University of Texas - MD Anderson Cancer Center, Houston
A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
RekruterenFase 2
- Jade Clinical Site, Houston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruterenFase 3
- Baylor College of Medicine, Houston
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RekruterenFase 2
- The University of Texas MD Anderson Cancer Center, Houston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
RekruterenFase 3
- Baylor College of Medicine, Houston
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
RekruterenFase 3
- Nephro Asso North Illinois Indiana, Houston
A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition
RekruterenFase 2
- Texas Children's Hospital, Houston
A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)
RekruterenFase 1/2
- MD Anderson Texas Medical Center, Houston
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
RekruterenFase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Immuunsysteem en aandoeningen studies in andere steden
- Washington, DC13 studies
- New York City, NY12 studies
- Boston, MA10 studies
- Philadelphia, PA10 studies
- Atlanta, GA9 studies
- Portland, OR9 studies
- Cleveland, OH8 studies
- Chicago, IL8 studies
- Los Angeles, CA8 studies
- Milwaukee, WI6 studies
- Seattle, WA6 studies
- Cedar Rapids, IA6 studies
Andere studies in Houston
- Niet-kleincellige longkanker145 studies
- Borstkanker126 studies
- Kanker (alle vormen)121 studies
- Metastatische kanker104 studies
- Colorectale kanker102 studies
- Eierstokkanker89 studies
- Acute myeloïde leukemie85 studies
- Longkanker78 studies
- Prostaatkanker76 studies
- Endometriumkanker68 studies
- Aldermeesklierkanker61 studies
- Melanoom59 studies
Van ClinicalTrials.gov, gegevens opgehaald op 5 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.